Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Travel Grants 2019, France 2019-10-01 --02

Reference number
Coordinator RespiHeart AB
Funding from Vinnova SEK 15 000
Project duration September 2019 - October 2019
Status Completed

Important results from the project

Based on a unique method, RespiHeart aims at driving product development and CE certification in cooperation with established medtech and/or pharma actors. The purpose of the project has been to initiate contacts to enable the next step according to this strategy. In summary, the project has been successful and has met the objectives.

Expected long term effects

The company has got the opportunity to present its concept and strategy to investors as well as representatives for big pharma and French innovation hubs and networks. Further, a number of face-to-face meetings have been held with medtech participants and French life science startups. Follow-up and next step in relation to new contacts are currently ongoing.

Approach and implementation

RespiHeart´s CEO participated in the conference event "French-Swedish Life Science Days 2019", that was arranged by Business Sweden and partners on behalf of Vinnova, in Paris October 1-2 2019.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 30 September 2019

Reference number 2019-04480

Page statistics